Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-20-001943

VP, Clinical&Translational Sc gave up 1,849 shares (to pay taxes)

  • VP, Clinical&Translational Sc acquired 6,230 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-02-18 Grant or award +5,049 49,194 D: show line 1 in the form
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-02-18 Shares withheld for taxes −1,498 $14.68 $21,991 47,696 D: show line 2 in the form
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-02-18 Grant or award +1,181 48,877 D: show line 3 in the form
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-02-18 Shares withheld for taxes −351 $14.68 $5,153 48,526 D: show line 4 in the form
Loading xslF345X03/edgar.xml…